News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Bio-Logic Systems Corp. Awarded Phase II Grant of $1 Million by The National Institutes of Health for Feasibility Study (PR Newswire)Bio-logic Systems Corp. today announced that after the successful completion of a study measuring the feasibility of a valuable new clinical evaluation method for detecting minute acoustic tumors, the National Institutes of Health awarded the company a Phase II grant of approximately $1 million to develop advanced Auditory Brainstem Response technology and collect clinical data on normal patients and those with small acoustic brain tumors.- Jun 26 8:00 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010626/cgtu027.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740